The opioid crisis

Stories of impact: O'Brien Institute for Public Health
Stories of impact: The opioid crisis

It’s been called the epidemic in the shadow of a pandemic. Since the onset of the COVID-19 pandemic in early 2020, the number of opioid-related deaths in Alberta has risen to an average of more than 100 per month. In response, clinician and social scientists at the O’Brien Institute have tackled this public health emergency from many fronts, such as through real-time research, through public awareness and by supporting frontline healthcare workers.

As COVID-19 raged, stealing the focus and resources required to stem the human cost exacted by the opioid crisis, the Institute’s Street CCRED (Community Capacity in Research, Education and Development) initiative mobilized its networks – and the expertise within them – to facilitate the training of dozens of community and front line care providers on the use of naloxone kits, an effective intervention in preventing opioid poisoning deaths. Street CCRED, and other Institute members, have also tried to address the societal impact of the crisis by becoming keen, public spokespeople for the epidemic, and for those affected by it.

Members, such as Bonnie Larson, MD, have become fixtures in provincial and national media coverage, where they have raised awareness of this epidemic’s extent, and the critical need for a holistic approach to this challenge.

Knowledge exchange around the opioid crisis on the part of Institute members has gone beyond participation in media discourse. It has also involved community engagement in the form of virtual events, such as the collaboration between Street CCRED and community partners, to host a virtual screening of a locally produced documentary titled “Harm: Alberta’s Preventable Overdose Crisis”. A panel made up of members from across the country, and attendees from Europe, the United States and Australia, gathered virtually following the film to explore prevention, harm reduction, treatment, and recovery.

Opioid crisis

Dr. Bonnie Larson (left) and Dr. Jennifer Jackson (right) are among the O'Brien Institute members working to address Alberta's opioid crisis.

Meanwhile, Jennifer Jackson, PhD, studied the efficacy of Alberta’s Injectable Opioid Agonist Treatment (iOAT) program, just as the program was about to be defunded in early 2021. Her work showed that the program was not only effective in saving lives, but in how patients have been able to move past their dependency and into a more normal life. Although renamed, the services provided by the iOAT are now funded through to 2023.

Institute researchers continue to work to gather the insights necessary to effectively face this epidemic head on, investigating everything from how to address needle waste and supply safety, to the unique challenges besieging First Nations and the use of social media to eradicate the stigma that exists around this crisis.

This Story of Impact is from the 2020-2021 O'Brien Institute annual report. Read the report here